✦ LIBER ✦

Anti-TNF therapies have eliminated the need for steroids in pediatric Crohn's disease

✍ Scribed by Dr. Richard J. Grand

Book ID: 110085975
Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 63 KB
Volume: 7
Category: Article
ISSN: 1078-0998
DOI: 10.1097/00054725-200111000-00013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-TNF therapies have eliminated the n

Anti-TNF therapies have eliminated the need for steroids in pediatric Crohn's disease: Pro. why use steroids if safer therapies are available?

✍ Dr. Robert N. Baldassano; Richard J. Grand 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Anti-TNF therapies have eliminated the n

Anti-TNF therapies have eliminated the need for steroids in pediatric Crohn's disease: Con. why use a drug with an unknown long-term safety profile if more established therapies will be effectives?

✍ Dr. Anne M. Griffiths 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Anti-tnf therapy for Crohn's disease: A

Anti-tnf therapy for Crohn's disease: A perspective (infliximab is not the drug we have been waiting for)

✍ Dr. Fergus Shanahan 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB 👁 3 views

Fecal calprotectin, lactoferrin, and end

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease

✍ Taina Sipponen; Erkki Savilahti; Päivi Kärkkäinen; Kaija-Leena Kolho; Hannu Nuut 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

Background: Fecal calprotectin and lactoferrin are promising noninvasive biomarkers for intestinal inflammation. In Crohn's disease (CD), during anti-TNF-alpha (TNF-␣) treatment, the clinical significance of these markers has, however, been insufficiently explored. Methods: Among CD patients receiv